Pink Sheet Podcast: US COVID-19 Booster Plan, Restated PDUFA Fees, More FDA Adcomm Power?

Pink Sheet reporter explains the increased pressure on the FDA now that a coronavirus vaccine booster plan is in place, the surprising results of a survey of agency advisory committee members, and the recalculation of FY 2022 PDUFA fees.